R.K. Bhamra

639 total citations
23 papers, 500 citations indexed

About

R.K. Bhamra is a scholar working on Analytical Chemistry, Spectroscopy and Pharmacology. According to data from OpenAlex, R.K. Bhamra has authored 23 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Analytical Chemistry, 8 papers in Spectroscopy and 6 papers in Pharmacology. Recurrent topics in R.K. Bhamra's work include Analytical Methods in Pharmaceuticals (11 papers), Analytical Chemistry and Chromatography (8 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). R.K. Bhamra is often cited by papers focused on Analytical Methods in Pharmaceuticals (11 papers), Analytical Chemistry and Chromatography (8 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). R.K. Bhamra collaborates with scholars based in United Kingdom, United States and Germany. R.K. Bhamra's co-authors include David W. Holt, Robert J. Flanagan, Christine E. Swenson, G. Storey, I. Jane, Clemens Unger, Joachim Drevs, Ulrich Massing, K. Mross and Lois E. Bolcsak and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Chromatography A and Heart.

In The Last Decade

R.K. Bhamra

22 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.K. Bhamra United Kingdom 11 116 106 104 89 88 23 500
Marika Kamberi United States 15 72 0.6× 213 2.0× 65 0.6× 61 0.7× 65 0.7× 25 798
Yuji Horikiri Japan 17 43 0.4× 37 0.3× 192 1.8× 37 0.4× 90 1.0× 24 758
Prasad N.V Tata United States 8 87 0.8× 25 0.2× 38 0.4× 54 0.6× 27 0.3× 11 355
J. Domenech Spain 13 30 0.3× 33 0.3× 49 0.5× 33 0.4× 42 0.5× 28 799
Jordan L. Cohen United States 14 30 0.3× 64 0.6× 13 0.1× 46 0.5× 24 0.3× 28 481
Jean Grellet France 12 88 0.8× 20 0.2× 10 0.1× 104 1.2× 46 0.5× 27 545
Nadia Miraglia Italy 17 28 0.2× 37 0.3× 8 0.1× 132 1.5× 98 1.1× 42 781
R.J. Prankerd United States 13 24 0.2× 15 0.1× 75 0.7× 74 0.8× 71 0.8× 29 519
Yasumasa Fukushima Japan 15 10 0.1× 72 0.7× 80 0.8× 203 2.3× 86 1.0× 75 1.1k
Howard J. Lambert United States 14 62 0.5× 9 0.1× 13 0.1× 94 1.1× 44 0.5× 21 510

Countries citing papers authored by R.K. Bhamra

Since Specialization
Citations

This map shows the geographic impact of R.K. Bhamra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.K. Bhamra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.K. Bhamra more than expected).

Fields of papers citing papers by R.K. Bhamra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.K. Bhamra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.K. Bhamra. The network helps show where R.K. Bhamra may publish in the future.

Co-authorship network of co-authors of R.K. Bhamra

This figure shows the co-authorship network connecting the top 25 collaborators of R.K. Bhamra. A scholar is included among the top collaborators of R.K. Bhamra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.K. Bhamra. R.K. Bhamra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bhamra, R.K., et al.. (2010). A randomized, multiple-dose parallel study to compare the pharmacokinetic parameters of synthetic conjugated estrogens, A, administered as oral tablet or vaginal cream. Menopause The Journal of The North American Menopause Society. 18(4). 393–399. 4 indexed citations
2.
Bhamra, R.K., et al.. (2010). Pharmacokinetics of a modified-release estrogen tablet.. PubMed. 55(9-10). 404–10.
3.
Mross, K., Ulrich Massing, Joachim Drevs, et al.. (2004). Pharmacokinetics of liposomal doxorubicin (TLC-D99; Myocet) in patients with solid tumors: an open-label, single-dose study. Cancer Chemotherapy and Pharmacology. 54(6). 514–524. 110 indexed citations
4.
Bhamra, R.K., et al.. (2003). Toxicity and disposition of TLC ELL-12 (liposomal antitumor ether lipid) in Sprague-Dawley rats. Anti-Cancer Drugs. 14(3). 183–191. 2 indexed citations
5.
Bhamra, R.K., Lois E. Bolcsak, Imran Ahmad, et al.. (2003). Activity, pharmacokinetics and tissue distribution of TLC ELL-12 (liposomal antitumor ether lipid) in rats with transplantable, s.c. methylnitrosourea-induced tumors. Anti-Cancer Drugs. 14(6). 481–486. 5 indexed citations
7.
Bhamra, R.K., et al.. (1990). High-performance liquid chromatographic method for the measurement of buflomedil in plasma and serum. Journal of Chromatography B Biomedical Sciences and Applications. 532(1). 187–192. 3 indexed citations
8.
Bhamra, R.K., et al.. (1990). High performance liquid chromatographic measurement of bisoprolol in plasma. Biomedical Chromatography. 4(4). 178–180. 9 indexed citations
9.
Galustian, Christine, et al.. (1990). High-performance liquid chromatographic method for the measurement of nicardipine in plasma or serum. Journal of Chromatography B Biomedical Sciences and Applications. 530(2). 463–468. 13 indexed citations
10.
Till, Jan, E A Shinebourne, Edward Rowland, et al.. (1989). Paediatric use of flecainide in supraventricular tachycardia: clinical efficacy and pharmacokinetics.. Heart. 62(2). 133–139. 36 indexed citations
11.
Flanagan, Robert J., et al.. (1988). Measurement of Cardioactive Drugs in Biological Samples by HPLC. Journal of Liquid Chromatography. 11(5). 1015–1040. 9 indexed citations
12.
Bhamra, R.K., et al.. (1987). HPLC measurement of diltiazem and desacetyldiltiazem in serum or plasma. Biomedical Chromatography. 2(4). 180–182. 4 indexed citations
13.
Bhamra, R.K., et al.. (1987). Column liquid chromatographic measurement of betaxolol in plasma or serum. Journal of Chromatography B Biomedical Sciences and Applications. 417(1). 229–232. 5 indexed citations
14.
Jackson, Graham, et al.. (1987). Plasma flecainide concentrations following acute myocardial infarction. International Journal of Cardiology. 15(3). 341–346. 1 indexed citations
15.
Bhamra, R.K., Robert J. Flanagan, & David W. Holt. (1986). Measurement of penbutolol and 4‐hydroxypenbutolol in plasma or serum by HPLC. Biomedical Chromatography. 1(3). 140–142. 2 indexed citations
16.
Bhamra, R.K., Robert J. Flanagan, & David W. Holt. (1986). High-performance liquid chromatographic measurement of prazosin and terazosin in biological fluids. Journal of Chromatography B Biomedical Sciences and Applications. 380(1). 216–221. 17 indexed citations
17.
Miller, Mark R., et al.. (1986). Verapamil and breast-feeding. European Journal of Clinical Pharmacology. 30(1). 125–126. 23 indexed citations
18.
Bhamra, R.K., et al.. (1983). High-Performance Liquid Chromatographic Measurement of Atenolol. Therapeutic Drug Monitoring. 5(3). 313–318. 17 indexed citations
19.
Holt, D W, et al.. (1982). High performance liquid chromatographic measurement of atenolol placental transfer and expression in breast milk. British Journal of Clinical Pharmacology. 14(1). 148–149. 5 indexed citations
20.
Flanagan, Robert J., G. Storey, R.K. Bhamra, & I. Jane. (1982). High performance liquid chromatographic analysis of basic drugs on silica columns using non-aqueous ionic eluents. Journal of Chromatography A. 247(1). 15–37. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026